Literature DB >> 10667404

Syringohydromyelia in Cavalier King Charles spaniels.

C Rusbridge1, J E MacSweeny, J V Davies, K Chandler, S N Fitzmaurice, R Dennis, R Cappello, S J Wheeler.   

Abstract

Syringohydromyelia secondary to foramen magnum overcrowding is described in seven Cavalier King Charles spaniels. Clinical signs were consistent with a central spinal cord lesion. The most common signs were persistent scratching at the shoulder region with apparent neck, thoracic limb, or ear pain and thoracic limb lower motor neuron deficits. The diagnosis was made by magnetic resonance imaging. The syringohydromyelia is postulated to be a consequence of an occipital bone malformation resulting in a small caudal fossa and cerebellar herniation. Clinical signs improved but did not completely resolve when the dogs received treatment with corticosteroids or nonsteroidal anti-inflammatory drugs.

Entities:  

Mesh:

Year:  2000        PMID: 10667404     DOI: 10.5326/15473317-36-1-34

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  28 in total

1.  Syringomyelia in the Cavalier King Charles spaniel (CKCS) dog.

Authors:  Katheryn C Wolfe; Roberto Poma
Journal:  Can Vet J       Date:  2010-01       Impact factor: 1.008

2.  Constrictive myelopathy in an 11-year-old West Highland terrier dog.

Authors:  Courtney A Gallant
Journal:  Can Vet J       Date:  2020-12       Impact factor: 1.008

3.  Syringohydromyelia in horses: 3 cases.

Authors:  Brett A Sponseller; Beatrice T Sponseller; Cody J Alcott; Karen Kline; Jesse Hostetter; Eric L Reinertson; Amanda Fales-Williams
Journal:  Can Vet J       Date:  2011-02       Impact factor: 1.008

4.  Increase in cerebellar volume in Cavalier King Charles Spaniels with Chiari-like malformation and its role in the development of syringomyelia.

Authors:  Thomas A Shaw; Imelda M McGonnell; Colin J Driver; Clare Rusbridge; Holger A Volk
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

5.  Comparison of the Relationship between Cerebral White Matter and Grey Matter in Normal Dogs and Dogs with Lateral Ventricular Enlargement.

Authors:  Martin J Schmidt; Steffi Laubner; Malgorzata Kolecka; Klaus Failing; Andreas Moritz; Martin Kramer; Nele Ondreka
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

6.  Magnetic resonance imaging signs of high intraventricular pressure--comparison of findings in dogs with clinically relevant internal hydrocephalus and asymptomatic dogs with ventriculomegaly.

Authors:  Steffi Laubner; Nele Ondreka; Klaus Failing; Martin Kramer; Martin J Schmidt
Journal:  BMC Vet Res       Date:  2015-08-01       Impact factor: 2.741

7.  Changes over time in craniocerebral morphology and syringomyelia in cavalier King Charles spaniels with Chiari-like malformation.

Authors:  Colin J Driver; Luisa De Risio; Sarah Hamilton; Clare Rusbridge; Ruth Dennis; Imelda M McGonnell; Holger A Volk
Journal:  BMC Vet Res       Date:  2012-11-08       Impact factor: 2.741

8.  Quantitative trait loci (QTL) study identifies novel genomic regions associated to Chiari-like malformation in Griffon Bruxellois dogs.

Authors:  Philippe Lemay; Susan P Knowler; Samir Bouasker; Yohann Nédélec; Simon Platt; Courtenay Freeman; Georgina Child; Luis B Barreiro; Guy A Rouleau; Clare Rusbridge; Zoha Kibar
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

9.  Quantitative analysis of Chiari-like malformation and syringomyelia in the Griffon Bruxellois dog.

Authors:  Susan P Knowler; Angus K McFadyen; Courtenay Freeman; Marc Kent; Simon R Platt; Zoha Kibar; Clare Rusbridge
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

10.  Comparison of the endocranial- and brain volumes in brachycephalic dogs, mesaticephalic dogs and Cavalier King Charles spaniels in relation to their body weight.

Authors:  Martin J Schmidt; Kerstin H Amort; Klaus Failing; Melanie Klingler; Martin Kramer; Nele Ondreka
Journal:  Acta Vet Scand       Date:  2014-05-13       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.